Please check your internet connection and try again.
# Sinex (oxymetazoline)
## Overview
Oxymetazoline is a direct-acting sympathomimetic amine. It acts as an alpha-adrenergic agonist, causing vasoconstriction of the arterioles in the nasal mucosa, which reduces hyperemia and edema to relieve nasal congestion.
## Primary Indications
* Nasal congestion (common cold, sinusitis, allergic rhinitis).
* Off-label: Minor ocular redness (via separate ophthalmic formulations).
## Adult Dosing
* **Nasal Spray (0.05%):** 2–3 sprays in each nostril every 10–12 hours.
* **Maximum Dose:** Do not exceed 2 doses in any 24-hour period.
* **Duration Limit:** Maximum 3 consecutive days of use.
## Pediatric Dosing
* **Children ≥6 to <12 years:** 2–3 sprays of 0.025% solution in each nostril every 12 hours. Maximum 2 doses per 24 hours; limit use to 3 days.
* **Children <6 years:** Not recommended; safety and efficacy are not established.
## Dose Adjustments
* **Renal/Hepatic:** No formal dosage adjustments provided by manufacturers; however, use with caution in patients with severe impairment due to the potential for systemic absorption.
## Contraindications
* Hypersensitivity to oxymetazoline or any component of the formulation.
* Concurrent use (or within 14 days) of monoamine oxidase inhibitors (MAOIs).
## Adverse Effects
* **Local:** Rhinitis medicamentosa (rebound congestion), stinging, burning, dryness of nasal mucosa, or sneezing.
* **Systemic (if overused/ingested):** Hypertension, tachycardia, palpitations, headache, dizziness, nervousness, and insomnia. High risk of toxicity in pediatric patients if ingested.
## Key Drug Interactions
* **MAOIs:** May cause severe hypertensive crisis.
* **Tricyclic Antidepressants (TCAs) / Beta-blockers:** May potentiate hypertensive effects.
* **Other Sympathomimetics:** May lead to additive cardiovascular effects.
## Monitoring
* Monitor for development of rebound congestion (worsening symptoms despite continued use).
* Monitor blood pressure and heart rate if systemic absorption is suspected or in patients with pre-existing cardiovascular disease.
## Clinical Pearls
* **Rhinitis Medicamentosa:** This is the most critical risk. Prolonged use (beyond 3 days) causes the nasal mucosa to become dependent on the drug; withdrawal results in severe, intractable congestion.
* **Patient Education:** Clearly emphasize the 3-day rule. Patients often equate lack of immediate effect—or the onset of rebound congestion—with a need for more medication, fueling the cycle.
* **Toxicity:** Keep out of reach of children. Even small amounts of systemic ingestion can cause severe CNS depression and cardiovascular collapse in toddlers.
***
*Disclaimer: This information is for educational purposes and does not substitute for clinical judgment. Always verify current prescribing information, institutional protocols, and patient-specific factors before administration.*
